−0.0664EUR
−5.226MEUR
255.202KEUR
About NANEXA AB
Sector
Industry
CEO
David Westberg
Website
Headquarters
Uppsala
Employees (FY)
19
Founded
2010
ISIN
SE0007074166
Nanexa AB engages in the development, production, and distribution of medical nanotechnology products. The firm's product, PharmaShell, provides possibilities for drug administration, dosage, and for targeting of parenteral drugs. It also offers Nanexa gas barrier and antifungal coating. The company was founded by Mats Boman, Jan-Otto Carlsson, Christian Östberg, Anders Hårsta, Mårten Rooth, Jessica Östberg, and Anders Johansson in 2007 and is headquartered in Uppsala, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
